2022, Jun

Attgeno announces approval of initiation of Phase II clinical trial of Supernitro in patients with acute pulmonary hypertension

Attgeno AB today announced that it has received approval from the Swedish Medical Products Agency and the Swedish Ethical Review Authority to start a Phase II clinical trial of its lead drug candidate Supernitro as a potentially lifesaving treatment for patients with acute pulmonary hypertension after cardiac surgery. Read More